These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

484 related items for PubMed ID: 12875699

  • 21. Prognostic significance of serum vascular endothelial growth factor and endostatin in patients with hepatocellular carcinoma.
    Poon RT, Ho JW, Tong CS, Lau C, Ng IO, Fan ST.
    Br J Surg; 2004 Oct; 91(10):1354-60. PubMed ID: 15376182
    [Abstract] [Full Text] [Related]

  • 22. [Clinical significance of vascular endothelial growth factor in sera of patients with gynaecological malignant tumors].
    Peng XP, Li JD, Li MD, Ye XM, Yan WC.
    Ai Zheng; 2002 Feb; 21(2):181-5. PubMed ID: 12479072
    [Abstract] [Full Text] [Related]

  • 23. Serum levels of vascular endothelial growth factor, basic fibroblast growth factor and endostatin in human metastatic liver tumors.
    Miyashita M, Tajiri T, Yanagi K, Shimizu T, Futami R, Sasajima K, Tokunaga A.
    Hepatogastroenterology; 2003 Feb; 50(50):308-9. PubMed ID: 12749209
    [Abstract] [Full Text] [Related]

  • 24. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?
    Tabone MD, Landman-Parker J, Arcil B, Coudert MC, Gerota I, Benbunan M, Leverger G, Dosquet C.
    Clin Cancer Res; 2001 Mar; 7(3):538-43. PubMed ID: 11297245
    [Abstract] [Full Text] [Related]

  • 25. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
    Robak E, Woźniacka A, Sysa-Jedrzejowska A, Stepień H, Robak T.
    Eur Cytokine Netw; 2001 Mar; 12(3):445-52. PubMed ID: 11566625
    [Abstract] [Full Text] [Related]

  • 26. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA, Gadelhak SA, El-Morsi DA, Abdelaziz MM, Abbas AT, El-Emshaty HM.
    Hepatogastroenterology; 2009 Mar; 56(94-95):1417-24. PubMed ID: 19950803
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Altered expression of vascular endothelial growth factor, fibroblast growth factor-2 and endostatin in patients with hepatocellular carcinoma.
    Uematsu S, Higashi T, Nouso K, Kariyama K, Nakamura S, Suzuki M, Nakatsukasa H, Kobayashi Y, Hanafusa T, Tsuji T, Shiratori Y.
    J Gastroenterol Hepatol; 2005 Apr; 20(4):583-8. PubMed ID: 15836707
    [Abstract] [Full Text] [Related]

  • 29. High serum levels of vascular endothelial growth factor predict poor response to transarterial chemoembolization in hepatocellular carcinoma: a prospective study.
    Poon RT, Lau C, Yu WC, Fan ST, Wong J.
    Oncol Rep; 2004 May; 11(5):1077-84. PubMed ID: 15069550
    [Abstract] [Full Text] [Related]

  • 30. [Association of VEGF, uPA, ICAM-1 and PCNA expression with metastasis and recurrence in hepato cellular carcinoma].
    Meng C, Chen X.
    Zhonghua Wai Ke Za Zhi; 2002 Sep; 40(9):673-5. PubMed ID: 12411137
    [Abstract] [Full Text] [Related]

  • 31. Correlation of plasma level and immunohistochemical expression of vascular endothelial growth factor in patients with advanced colorectal cancer.
    Minagawa N, Nakayama Y, Hirata K, Onitsuka K, Inoue Y, Nagata N, Itoh H.
    Anticancer Res; 2002 Sep; 22(5):2957-63. PubMed ID: 12530025
    [Abstract] [Full Text] [Related]

  • 32. Elevated vascular endothelial growth factor levels in sera of patients with lung cancer.
    Takigawa N, Segawa Y, Fujimoto N, Hotta K, Eguchi K.
    Anticancer Res; 1998 Sep; 18(2B):1251-4. PubMed ID: 9615796
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with malignant bone tumors.
    Holzer G, Obermair A, Koschat M, Preyer O, Kotz R, Trieb K.
    Med Pediatr Oncol; 2001 Jun; 36(6):601-4. PubMed ID: 11344490
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
    Alexandrakis MG, Passam FH, Boula A, Christophoridou A, Aloizos G, Roussou P, Kyriakou DS.
    Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
    [Abstract] [Full Text] [Related]

  • 37. Elevated serum vascular endothelial growth factor and decreased survival in advanced laryngeal carcinoma.
    Teknos TN, Cox C, Yoo S, Chepeha DB, Wolf GT, Bradford CR, Carey TE, Fisher SG.
    Head Neck; 2002 Nov; 24(11):1004-11. PubMed ID: 12410536
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Correlation between epidermal growth factor and overexpression of vascular endothelial growth factor in hepatocellular carcinoma].
    Huang G, Yang L, Yang J, Liu H, Yang Z.
    Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):564-6. PubMed ID: 12667326
    [Abstract] [Full Text] [Related]

  • 40. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma].
    Moon JI, Kim JM, Jung GO, Chun JM, Choi GS, Park JB, Kwon CH, Kim SJ, Jo JW.
    Korean J Hepatol; 2008 Jun; 14(2):185-96. PubMed ID: 18617766
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.